Hospital
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center was paid $4.90M by Medicaid between Jan 2018 and Nov 2024, across 70 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 18% of everything it billed.
33Billing provider infoCEDARS-SINAI MEDICAL CENTER
WEST HOLLYWOOD, CA 90048
WEST HOLLYWOOD, CA 90048
33aNPI1891940326assigned 11/25/2008
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.90M
24GClaims80,778
24DCodes billed70
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#229 of 410
Median peer was paid$6.90M
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,135 | $174K | |
| 2019 | 10,272 | $98K | |
| 2020 | 9,912 | $500K | |
| 2021 | 16,408 | $1.93M | |
| 2022 | 10,485 | $1.04M | |
| 2023 | 9,600 | $739K | |
| 2024incomplete | 14,966 | $419K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 18% | 10,862 | 7,084 | $872K |
| 87497 | 14% | 828 | 476 | $681K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 9.7% | 12,338 | 7,575 | $474K |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 7.1% | 220 | 166 | $347K |
| 86900 | 6.4% | 2,767 | 1,486 | $312K | |
| 86850 | 5.2% | 2,730 | 1,415 | $253K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 4.3% | 7,323 | 5,384 | $210K |
| 87799 | 3.9% | 679 | 391 | $190K | |
| 83735 | 3.6% | 1,818 | 903 | $177K | |
| 82784 | 3.4% | 2,340 | 1,462 | $166K | |
| 86901 | 3.4% | 2,665 | 1,406 | $166K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 3.0% | 4,601 | 2,887 | $145K |
58 more codes
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 2.8% | 174 | $135K |
| 87496 | 2.8% | 174 | $135K | |
| 83615 | 2.7% | 1,827 | $131K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.6% | 3,577 | $76K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,000 | $35K |
| 96401 | <1% | 544 | $35K | |
| J0897 | Injection, denosumab, 1 mg | <1% | 83 | $30K |
| Q3014 | Telehealth originating site facility fee | <1% | 2,177 | $28K |
| Z7500 | <1% | 786 | $27K | |
| 86334 | <1% | 836 | $22K | |
| 36430 | <1% | 265 | $20K | |
| 77334 | <1% | 118 | $19K | |
| C9062 | Injection, daratumumab 10 mg and hyaluronidase-fihj | <1% | 20 | $19K |
| 84165 | <1% | 1,092 | $18K | |
| 0760 | <1% | 1,701 | $17K | |
| P9040 | Red blood cells, leukocytes reduced, irradiated, each unit | <1% | 312 | $16K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 2,028 | $15K |
| 77300 | <1% | 70 | $12K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,365 | $11K |
| 96367 | <1% | 397 | $11K | |
| 96415 | <1% | 698 | $10K | |
| 96417 | <1% | 905 | $10K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 953 | $10K |
| 83883 | <1% | 1,076 | $9K | |
| 77336 | <1% | 330 | $9K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 260 | $7K |
| 82728 | <1% | 188 | $7K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 444 | $6K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,558 | $5K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 186 | $4K |
| 0510 | <1% | 2,493 | $3K | |
| 83521 | <1% | 347 | $3K | |
| 84100 | <1% | 16 | $2K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 112 | $2K |
| J3490 | Unclassified drugs | <1% | 167 | $2K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | <1% | 17 | $2K |
| 0272 | <1% | 363 | $1K | |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | <1% | 529 | $1K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 40 | $942.50 |
| 82378 | <1% | 356 | $884.49 | |
| 86300 | <1% | 190 | $869.60 | |
| 0761 | <1% | 13 | $256.64 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 54 | $256.07 |
| J1453 | Injection, fosaprepitant, 1 mg | <1% | 71 | $232.42 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 173 | $195.11 |
| 0949 | <1% | 24 | $175.94 | |
| 81001 | <1% | 20 | $154.94 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 34 | $149.81 |
| 84439 | <1% | 79 | $149.09 | |
| 86301 | <1% | 43 | $130.42 | |
| 83550 | <1% | 63 | $104.26 | |
| 83540 | <1% | 77 | $89.08 | |
| 85027 | <1% | 17 | $80.05 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 34 | $34.20 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 65 | $27.42 |
| 86304 | <1% | 15 | $14.80 | |
| 84481 | <1% | 16 | $11.98 | |
| 85610 | <1% | 35 | $4.32 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMAQUERIA, LISA (VP, FINANCE AND CRO)